Prostate cancer has an estimated national incidence of 268 490 cases in 2022.1 Approximately 1 in 8 men living in the United States will be diagnosed with prostate cancer during their lifetime.2 Research into the mechanistic underpinnings driving prostate cancer development and progression has focused predominantly on androgen receptor–dependent mechanisms. Here, AR is linked to prostate carcinoma.